Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis.
Podestà M, Piaggio G, Sessarego M, Pitto A, Figari O, Soracco M, Carella AM, Dejana A, Rosti V, Fugazza G, Ravera G, Lerma E, Cazzola M, Bacigalupo A, Frassoni F. Podestà M, et al. Among authors: soracco m. Exp Hematol. 2000 Feb;28(2):210-5. doi: 10.1016/s0301-472x(99)00147-2. Exp Hematol. 2000. PMID: 10706077 Free article.
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F. Carella AM, et al. Among authors: soracco m. Bone Marrow Transplant. 1996 Feb;17(2):201-5. Bone Marrow Transplant. 1996. PMID: 8640167 Clinical Trial.
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation.
Bacigalupo A, Soracco M, Vassallo F, Abate M, Van Lint MT, Gualandi F, Lamparelli T, Occhini D, Mordini N, Bregante S, Figari O, Benvenuto F, Sessarego M, Fugazza G, Carlier P, Valbonesi M. Bacigalupo A, et al. Among authors: soracco m. Bone Marrow Transplant. 1997 May;19(9):927-32. doi: 10.1038/sj.bmt.1700762. Bone Marrow Transplant. 1997. PMID: 9156268 Clinical Trial.
Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia.
Carella AM, Lerma E, Corsetti MT, Dejana A, Basta P, Vassallo F, Abate M, Soracco M, Benvenuto F, Figari O, Podestá M, Piaggio G, Ferrara R, Sessarego M, Parodi C, Pizzuti M, Rubagotti A, Occhini D, Frassoni F. Carella AM, et al. Among authors: soracco m. Blood. 1999 Mar 1;93(5):1534-9. Blood. 1999. PMID: 10029581 Free article. Clinical Trial.
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation.
Dominietto A, Lamparelli T, Raiola AM, Van Lint MT, Gualandi F, Berisso G, Bregante S, Di Grazia C, Soracco M, Pitto A, Frassoni F, Bacigalupo A. Dominietto A, et al. Among authors: soracco m. Blood. 2002 Dec 1;100(12):3930-4. doi: 10.1182/blood-2002-01-0339. Epub 2002 Aug 1. Blood. 2002. PMID: 12393584 Free article.
Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte-colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia.
Carella AM, Frassoni F, Podestá M, Pungolino E, Pollicardo N, Ferrero R, Soracco M. Carella AM, et al. Among authors: soracco m. J Hematother. 1994 Fall;3(3):199-202. doi: 10.1089/scd.1.1994.3.199. J Hematother. 1994. PMID: 7530135 Clinical Trial.
24 results